Indivior (LSE:INDV)
About
Last updated 11-08-2020, 01:26:03pm BSTRelated Articles
-
Is the Abcam share price too expensive?
The Abcam share price is volatile as speculation keeps it in the news. Has it got the potential to soar or is it overpriced? Read More »
-
Top shares for December 2019
We asked our freelance writers to share their top stock picks for the month. Read More »
-
Indivior surges! Time to buy and make a killing?
Shares in this drug manufacturer are surging higher. Is now the time to buy or are there warning signs to watch? Read More »
-
Forget the cash ISA! I’d buy this FTSE 100 dividend bargain today
This former FTSE 100 (INDEXFTSE: UKX) darling has fallen on hard times, but this could be the perfect opportunity for savvy investors, writes Rupert... Read More »
-
Is the Reckitt Benckiser share price finally low enough to make the stock a bargain for me?
I think there’s a strong case to buy shares of Reckitt Benckiser Group plc (LON: RB) with good growth prospects, despite its legal challenges. Read More »
-
Is it game over for pharma flop Indivior after 75% crash?
What's gone wrong at Indivior plc (LON:INDV) and what would I do now? Roland Head gives his verdict. Read More »
-
An 8% FTSE 100 dividend stock I’d buy today, and a falling knife I’d avoid
This 8% FTSE 100 (INDEXFTSE:UKX) dividend stock looks reasonably priced, says Roland Head. Read More »
-
Could this year’s biggest FTSE 250 fallers be 2019’s biggest winners?
These FTSE 250 (INDEXFTSE:MCX) stocks have fallen 65% or more. Is it time to load up for 2019? Read More »
-
Forget 1.5% from a cash ISA. FTSE 100 member AstraZeneca is up by 20% in 2018
Roland Head asks whether FTSE 100 (INDEXFTSE:UKX) dividend stock AstraZeneca plc (LON:AZN) deserves a buy rating. Read More »
-
These FTSE 250 stocks have plunged 50% in 12 months. Is it time to buy?
These falling FTSE 250 (INDEXFTSE: MCX) stocks could be worth a look, according to Rupert Hargreaves. Read More »